4th Quarter - Termination

CROSSROADS STRATEGIES, LLC for LUMARA HEALTH

Firm
Client
Income
$60,000
Expenses
—
Terminated
Dec 31, 2014

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3089 (113th)

Budget/Appropriations BUD

Issues related to FY2015 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations and H.R.4800/S.2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2389 (113th), H.R. 4800 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.